Key result
NOACs offer significant advantages over warfarin but require specific nursing considerations and teaching strategies.
Why the study?
A new class of anticoagulant drugs called novel oral anticoagulants (NOACs) has emerged with significant advantages over warfarin, requiring comprehensive review.
This review provides a comprehensive overview of novel oral anticoagulants, including clinical pharmacology and nursing considerations.
Supports NOAC-specific nursing education; leaves open prospective validation of teaching strategies.
In Brief Recently, a new class of anticoagulant drugs has emerged, called novel oral anticoagulants (NOACs), which have significant advantages over warfarin. This article provides a review of the actions, indications, contraindications, adverse reactions, and reversal agents for four new drugs. Nursing considerations and teaching strategies for patients taking NOACs are also discussed. Recently, a new class of anticoagulant drugs has emerged, called novel oral anticoagulants (NOACs), which have significant advantages over warfarin. This article provides a review of the actions, indications, contraindications, adverse reactions, and reversal agents for four new drugs. Nursing considerations and teaching strategies for patients taking NOACs are also discussed.
No takes yet. Share an insight, caveat, or question.
Geraldine M. O'Leary (2017) conducted a review in Anticoagulation. Novel oral anticoagulants (NOACs) vs. Warfarin was evaluated. Novel oral anticoagulants (NOACs) offer significant advantages over warfarin, requiring specific nursing considerations and teaching strategies for their actions, indications, and adverse reactions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: